Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2014 Jun;8(6):405-13.
doi: 10.1016/j.jash.2014.03.003. Epub 2014 Mar 15.

Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality

Affiliations
Multicenter Study

Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality

Marguerite R Irvin et al. J Am Soc Hypertens. 2014 Jun.

Abstract

Apparent treatment-resistant hypertension (aTRH) is defined as uncontrolled hypertension despite the use of three or more antihypertensive medication classes or controlled hypertension while treated with four or more antihypertensive medication classes. We evaluated the association of aTRH with incident stroke, coronary heart disease (CHD), and all-cause mortality. Participants from the population-based REasons for Geographic And Racial Differences in Stroke (REGARDS) Study treated for hypertension with aTRH (n = 2043) and without aTRH (n = 12,479) were included. aTRH was further categorized as controlled aTRH (≥4 medication classes and controlled hypertension) and uncontrolled aTRH (≥3 medication classes and uncontrolled hypertension). Over a median of 5.9, 4.4, and 6.0 years of follow-up, the multivariable adjusted hazard ratio for stroke, CHD, and all-cause mortality associated with aTRH versus no aTRH was 1.25 (0.94-1.65), 1.69 (1.27-2.24), and 1.29 (1.14-1.46), respectively. Compared with controlled aTRH, uncontrolled aTRH was associated with CHD (hazard ratio, 2.33; 95% confidence interval, 1.21-4.48), but not stroke or mortality. Comparing controlled aTRH with no aTRH, risk of stroke, CHD, and all-cause mortality was not elevated. aTRH was associated with an increased risk for coronary heart disease and all-cause mortality.

Keywords: Resistant hypertension; antihypertensives; outcomes; severe hypertension.

PubMed Disclaimer

Conflict of interest statement

Conflicts: None to disclose

Figures

Figure 1
Figure 1
Incidence rates of stroke, coronary heart disease, and all-cause mortality among REGARDS participants with and without apparent treatment resistant hypertension. aTRH = apparent treatment resistant hypertension; systolic blood pressure ≥ 140 mm Hg or diastolic blood pressure ≥ 90 mm Hg with ≥ 3 antihypertensive medication classes (uncontrolled aTRH) or systolic blood pressure < 140 mmHg and diastolic blood pressure< 90 mm Hg and treatment with ≥ 4 antihypertensive medication classes (controlled aTRH). No aTRH = no apparent treatment resistant hypertension; systolic blood pressure < 140 mmHg and diastolic blood pressure< 90 mm Hg while treated with < 4 antihypertensive medication classes or systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mm Hg while treated with 1 or 2 antihypertensive medication classes. Bar represents incidence rate, line represents 95% confidence interval. See Supplemental Table 2 for the incidence rates and 95% confidence intervals.

References

    1. Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008 Jun;117(25):e510–526. - PubMed
    1. Egan BM, Zhao Y, Axon RN, Brzezinski WA, Ferdinand KC. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation. 2011 Aug;124(9):1046–1058. - PMC - PubMed
    1. Persell SD. Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension. 2011 Jun;57(6):1076–1080. - PubMed
    1. de la Sierra A, Segura J, Banegas JR, et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension. 2011 May;57(5):898–902. - PubMed
    1. Irvin MR, Shimbo D, Mann DM, et al. Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension. J Clin Hypertens (Greenwich) 2012 Oct;14(10):694–700. - PMC - PubMed

Publication types

MeSH terms

Substances